Return On Equity of Transcode Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Transcode Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Transcode Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -685%, a 5.5% decline year-over-year.
  • Transcode Therapeutics, Inc. annual Return On Equity for 2024 was -1210%, a 29% decline from 2023.
  • Transcode Therapeutics, Inc. annual Return On Equity for 2023 was -935%, a 444% decline from 2022.
  • Transcode Therapeutics, Inc. annual Return On Equity for 2022 was -172%, a 92% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Transcode Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -685% -36% -5.5% 01 Jul 2025 30 Sep 2025
Q2 2025 -612% -15% -2.5% 01 Apr 2025 30 Jun 2025
Q1 2025 -907% -372% -70% 01 Jan 2025 31 Mar 2025
Q4 2024 -1210% -275% -29% 01 Oct 2024 31 Dec 2024
Q3 2024 -649% +173% +21% 01 Jul 2024 30 Sep 2024
Q2 2024 -597% -40% -7.2% 01 Apr 2024 30 Jun 2024
Q1 2024 -535% -215% -67% 01 Jan 2024 31 Mar 2024
Q4 2023 -935% -763% -444% 01 Oct 2023 31 Dec 2023
Q3 2023 -822% -717% -683% 01 Jul 2023 30 Sep 2023
Q2 2023 -557% -484% -666% 01 Apr 2023 30 Jun 2023
Q1 2023 -320% -278% -661% 01 Jan 2023 31 Mar 2023
Q4 2022 -172% -82% -92% 01 Oct 2022 31 Dec 2022
Q3 2022 -105% +177% +63% 01 Jul 2022 30 Sep 2022
Q2 2022 -73% -155% -188% 01 Apr 2022 30 Jun 2022
Q1 2022 -42% -221% -123% 01 Jan 2022 31 Mar 2022
Q4 2021 -89% -200% -180% 01 Oct 2021 31 Dec 2021
Q3 2021 -282% 01 Jul 2021 30 Sep 2021
Q2 2021 82% 01 Apr 2021 30 Jun 2021
Q1 2021 179% 01 Jan 2021 31 Mar 2021
Q4 2020 111% 01 Oct 2020 31 Dec 2020

Transcode Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -1210% -275% -29% 01 Jan 2024 31 Dec 2024
2023 -935% -763% -444% 01 Jan 2023 31 Dec 2023
2022 -172% -82% -92% 01 Jan 2022 31 Dec 2022
2021 -89% -200% -180% 01 Jan 2021 31 Dec 2021
2020 111% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.